Article

Viva, Iconix ink deal to make, distribute Rampage brand

Viva International Group and Iconix Brand Group have signed a multi-year licensing agreement for Viva to produce and distribute Iconix Group's Rampage Eyewear brand globally.

Key Points

Somerville, NJ-Viva International Group and Iconix Brand Group have signed a multi-year licensing agreement for Viva to produce and distribute Iconix Group's Rampage Eyewear brand globally.

Rampage Eyewear will consist of approximately 20 styles that feature a variety of handmade acetate and metal styles. Intricate treatments will include floral plaques, subtle logo treatments, and laser-etched detailing.

The new collection of optical styles will be presented at Vision Expo East 2009. An advertising campaign is scheduled for January 2009 to showcase the Rampage Eyewear brand's fashion-forward eyewear styles.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.